PROTEOSUITE
"PROTEOSUITE" is a word mark owned by Catalent Pharma Solutions, Inc., filed at the CIPO on July 12, 2023. It is registered and covers class 42 (Computer and Scientific Services).
- Status
- Registered
- Since November 21, 2025
- Filed
- July 12, 2023
- Registered
- November 21, 2025
- Expires
- November 21, 2035
- Application no.
- 2268883
- Registration no.
- TMA1361067
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns PROTEOSUITE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Catalent Pharma Solutions, Inc.
United States
Representative
Gowling WLG (Canada) LLP
Gowling WLG (Canada) LLP
What the mark covers
The products and services PROTEOSUITE is filed for, grouped by Nice class.
Research and development in the field of pharmaceutical research, namely, conducting pharmaceutical product developability assessments for protein degraders to identify orally bioavailable pharmaceutical candidates; Research and development in the field of oral drug formulations and drug dosage; Scientific and technological services, namely, scientific research, analysis, screening and testing in the field of oral drug formulation development; Research and development in the field of protein degrader drugs; Research and development in the field of small molecule therapeutics; Conducting scientific feasibility studies; Pharmaceutical research services; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical products development; Pharmaceutical drug development services; Analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; conducting early evaluations in the field of new pharmaceuticals; conducting research, development, and evaluations in the field of new pharmaceuticals; consulting services in the field of pharmaceutical research; medical research information in the fields of pharmaceuticals; pharmaceutical evaluation services; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; testing of pharmaceuticals
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Pending
- Advertised; Vol.72 Issue 3697
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Search Recorded
- Pre-Assessment Letter Sent; Goods or Services Not Acceptable
- Formalized
- Created
- Filed
About PROTEOSUITE
Who owns the trademark "PROTEOSUITE"?
The CIPO trademark "PROTEOSUITE" (application 2268883) is owned by Catalent Pharma Solutions, Inc.
What is the status of "PROTEOSUITE"?
Its status at the CIPO is: registered.
When was "PROTEOSUITE" registered?
It was registered on November 21, 2025 and is due to expire on November 21, 2035.
Get this data via the API
Everything on this page comes from the Signa API. Pull PROTEOSUITE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb35-bcb0-774a-bc3f-3e3e84deea50
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb35-bcb0-774a-bc3f-3e3e84deea50",
"object": "trademark",
"mark_text": "PROTEOSUITE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "2268883",
"filing_date": "2023-07-12",
"nice_classes": [
42
],
"owners": [
{
"name": "Catalent Pharma Solutions, Inc.",
"entity_id": "ent_019eb6fc-3d59-70de-b77a-e1780d3638e9"
}
]
}